Page 1 | Search Results | Archives of Pathology & Laboratory Medicine

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go

Maxwell L. Smith, MD, Lida P. Hariri, MD, PhD, Mari Mino-Kenudson, MD, Sanja Dacic, MD, PhD, Richard Attanoos, MBBS, FRCPath ...

Arch Pathol Lab Med (2020) 144 (12): 1477–1489.

https://doi.org/10.5858/arpa.2020-0052-RA

Published: 02 July 2020

View article titled, Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go

Journal Articles

E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists

Matthew J. Cecchini, MD, PhD, Sanjay Mukhopadhyay, MD, Andrea V. Arrossi, MD, Mary B. Beasley, MD, Yasmeen M. Butt, MD ...

Arch Pathol Lab Med (2020) 144 (12): 1490–1500.

https://doi.org/10.5858/arpa.2020-0024-RA

Published: 13 May 2020

View article titled, E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists

Journal Articles

Whence Lepidic ?: The History of a Canadian Neologism

Kirk D. Jones, MD

Arch Pathol Lab Med (2013) 137 (12): 1822–1824.

https://doi.org/10.5858/arpa.2013-0144-HP

Published: 12 August 2013

View article titled, Whence Lepidic ?: The History of a Canadian Neologism

Journal Articles

Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Kirk D. Jones, MD;, Andrew Churg, MD;, Douglas W. Henderson, MBBS, FRCPA, David M. Hwang, MD, PhD, Jenny Ma Wyatt, MBBS, FRCPA ...

Arch Pathol Lab Med (2013) 137 (8): 1054–1062.

https://doi.org/10.5858/arpa.2012-0511-OA

Published: 01 August 2013

View article titled, Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Journal Articles

Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

Juneko E. Grilley-Olson, MD, D. Neil Hayes, MD, MPH, Dominic T. Moore, MS, MPH, Kevin O. Leslie, MD, Matthew D. Wilkerson, PhD ...

Arch Pathol Lab Med (2012) 137 (1): 32–40.

https://doi.org/10.5858/arpa.2012-0033-OA

Published: 01 May 2012

View article titled, Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

NARROW

Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go

E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists

Whence Lepidic ?: The History of a Canadian Neologism

Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

Get Email Alerts

Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go

E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists

Whence Lepidic ?: The History of a Canadian Neologism

Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

Get Email Alerts

This Feature Is Available To Subscribers Only